Clinical Trial Update: Expanded Access of Sotorasib

View source ↗

Summary

Expanded access program for sotorasib (Amgen) in non-small cell lung cancer is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• sotorasib (sotorasib)

Snippet

Sponsor: Amgen | Conditions: Non Small-cell Lung Cancer, Locally Advanced Unresectable NSCLC | Status: NO_LONGER_AVAILABLE